Application of cystatin C reduction ratio to high-flux hemodialysis as an alternative indicator of the clearance of middle molecules

Korean J Intern Med. 2010 Mar;25(1):77-81. doi: 10.3904/kjim.2010.25.1.77. Epub 2010 Feb 26.

Abstract

Background/aims: Although high-flux (HF) dialyzers with enhanced membrane permeability are widely used in current hemodialysis (HD) practice, urea kinetic modeling is still being applied to indicate the adequacy of both low-flux (LF) and HF HD. In comparison with urea (molecular weight, 60 Da) and beta(2)-microglobulin (beta(2)MG, 12 kDa), cystatin C (CyC, 13 kDa) is a larger molecule that has attractive features as a marker for assessing solute clearance. We postulated that CyC might be an alternative for indicating the clearance of middle molecules (MMs), especially with HF HD.

Methods: Eighty-nine patients were divided into LF and HF groups. Using single pool urea kinetic modeling, the urea reduction ratio (URR) and equilibrated Kt/V(urea) (eKt/V(urea)) were calculated. The serum CyC concentrations were measured using particle-enhanced immunonephelometry. As indices of the middle molecular clearance, the reduction ratios of beta(2)MG and CyC were calculated.

Results: The beta(2)MG reduction ratio (beta(2)MGRR) and CyC reduction ratio (CyCRR) were higher in the HF group compared to the LF group. However, the URR and eKt/Vurea did not differ between the two groups. The CyCRR was significantly correlated with the eKt/V(urea) and beta(2)MGRR (r = 0.47 and 0.69, respectively, both p < 0.0001).

Conclusions: Compared to the LF dialyzer, the HF dialyzer removed CyC and beta(2)MG more efficiently. Unlike the beta(2)MGRR, the CyCRR was correlated with the eKt/V(urea) and beta(2)MGRR. This study suggests a role for the CyCRR as an alternative indicator of the removal of MMs.

Keywords: Cystatin C; Dialysis; beta 2-Microglobulin.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Biomarkers / blood
  • Case-Control Studies
  • Cystatin C / blood*
  • Female
  • Hemodialysis Solutions
  • Humans
  • Kidney Failure, Chronic / blood*
  • Kidney Failure, Chronic / therapy*
  • Male
  • Middle Aged
  • Models, Biological
  • Nephelometry and Turbidimetry / methods*
  • Renal Dialysis / methods*
  • Urea / blood
  • Uremia / blood
  • Uremia / therapy
  • beta 2-Microglobulin / blood

Substances

  • Biomarkers
  • Cystatin C
  • Hemodialysis Solutions
  • beta 2-Microglobulin
  • Urea